Hemo Organic Ltd to Hold Board Meeting to Review Q1 Un-audited Financial Results
Hemo Organic Ltd has scheduled a meeting of its Board of Directors for Wednesday, July 15, 2026, at 4:00 p.m. The gathering is set to address key business matters, including the review of the company's performance for the first quarter of the financial year.The primary agenda item slated for discussion is the consideration and approval of the Un-audited Financial Results of the Company for the quarter ending June 30, 2026. The Board will also review the accompanying Limited Review Report related to these results.
In addition to reviewing the financial performance, the meeting is scheduled to transact other business matters as per the circulated agenda. The appointment allows stakeholders an opportunity to consider the company's operational status and future direction following the completion of the first quarter.
Stock Price Movement
Hemo Organic Ltd. settled on Monday, with shares ticking up 4.97% to close at ₹22.16. The stock moved through a range during the session, bottoming out at ₹20.90 before reaching an intraday high of ₹22.16.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.